Quantcast

Latest Pharmaceutical sciences Stories

2014-08-11 08:28:49

SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, today announced that Scott Pancoast, president and CEO, will present at the 34th Annual Canaccord Genuity Growth Conference on Wednesday, August 13, 2014 at 5:00 p.m. Eastern Time in Boston. The live webcast presentation and replay will be available by visiting the Investor section of the Lpath website at www.Lpath.com. About Lpath San Diego-based Lpath,...

2014-08-11 08:28:44

PITTSBURGH, Aug. 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.(1) CEO...

2014-08-11 08:28:23

MELBOURNE, Australia, Aug. 11, 2014 /PRNewswire/ -- -- Single dose pharmacokinetic (PK) study reproduces earlier results -- Therapeutic oxymorphone blood levels achieved in all 15 subjects -- Drug elimination indicates favourable safety profile Australian drug delivery company, Phosphagenics Limited (the Company) (ASX: POH, OTCQX: PPGNY),announces that the first of its additional studies designed to further characterise the TPM®/Oxymorphone patch, in support of an...

2014-08-08 23:07:05

http://www.DrugNews.net is the largest source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) August 08, 2014 The birth control safety center at DrugNews.net is alerting women using the Mirena IUD contraceptive of new research information on the site. A recent study found a higher incidence of breast cancer among women using the device* DrugNews is a free resource for those using popular prescription drugs and...

2014-08-08 23:06:38

On August 5, the US FDA issued a safety communication on adverse events associated with the unapproved use of the Expression product as a dermal filler. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 08, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Expression Injectable. The FDA issued a...

2014-08-08 23:03:44

A delayed delivery of edible & concentrated marijuana products led to major news networks missing out on a historic moment, Wednesday night in Bellingham, WA. Luckily, cannabis industry media start-up Ganjapreneur.com was there to capture the moment for future generations. Bellingham, WA (PRWEB) August 08, 2014 On August 6th, Top Shelf Cannabis in Bellingham, WA made history as the first retailer in the state's recreational marijuana market to sell edible and concentrated products...

2014-08-08 23:00:24

The Pharmaceuticals Packing and Labeling Services industry has performed well over the past five years, with minor losses in 2009; and over the next five years, strong growth will continue as the number of individuals will healthcare increases and as patents on brand name drugs expire, causing the industry will benefit from generic manufacturers that will need industry services. For these reasons, industry research firm IBISWorld has added a report on the Pharmaceuticals Packing and...

2014-08-08 12:25:01

DUBLIN, Aug. 8, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Diabetic Neuropathy Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 R&D activities in the Diabetic Neuropathy sector are growing in terms of an increase in the number of mergers and acquisitions. Big pharmaceutical companies take up later-stage products from small companies, where efficacy has already been demonstrated, thereby cutting down...

2014-08-08 08:25:48

THE WOODLANDS, Texas, Aug. 8, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 2014 Wedbush Life Sciences Management Access Conference on Tuesday, August 12, 2014 at 10:55 AM EDT in New York City. Lexicon management will provide an overview of Lexicon's clinical development programs and milestones. A webcast of the presentation will be available through Lexicon's website at www.lexpharma.com. An archived...

2014-08-08 08:25:39

REDWOOD CITY, Calif., Aug. 8, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will be participating at three upcoming investor events. Details of the three events are as follows: Canaccord 34(th) Annual Growth ConferenceDate: Wednesday August 13(th) Location: Boston,...


Latest Pharmaceutical sciences Reference Libraries

Phytotherapy Research
2012-05-01 10:17:25

Phytotherapy Research is a monthly peer-reviewed scientific journal publishing original research papers, short communications, reviews, and letters on medicinal plant research. Topics include pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Short communications dealing with the pharmacology and screening...

More Articles (1 articles) »
Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related